A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.

Clinical trial NCT06381466 · TERMINATED

Trial details

NCT number: NCT06381466
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Dilated Cardiomyopathy

Start date: 2024-04-01
Primary completion: 2025-12-30
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.